Update on recognition and management of patients with acquired or inherited hypercoagulability.

Abstract excerpt

As many as 20% of individuals who develop venous thromboembolism (VTE) in an outpatient setting may have a mutation in factor V (factor V Leiden) or the prothrombin gene. Through testing for the inherited and acquired conditions for VTE, the clinician can develop strategies to prevent recurrences.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antiphospholipid Syndrome
• Share to Blood Coagulation Disorders
• Share to Factor V